Clinical Trial Update: Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris [Phase 2]

View source ↗

Summary

Phase 2 trial comparing CD2475/101 40 mg tablets to placebo and doxycycline for inflammatory lesions in acne vulgaris; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• CD2475/101 40 mg
• Doxycycline 100 mg (doxycycline)

Snippet

Sponsor: Galderma R&D | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2020-02-10